ProVision DiaRetin
Natural health product licensed in Canada
- Other names
- Helps to slow the progression of Diabetic & Hypertensive Retinopathy, Helps to slow the progression of Diabetic Retinopathy, Helps to slow the progression of Hypertensive Retinopathy, Ocuoo D&H, Ocuoo DiaRetin, Ocuoo HyRetina, ProVision D&H, ProVision HyRetina
- Licence holder
- Healtha Inc.
- NPN or DIN-HM
- 80129388
- Status
- Active licence
- Licence date
- 7 February 2024
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vaccinium myrtillus Source : Vaccinium myrtillus - Fruit Extract : Matériel brut sec Extraction ratio : 80:1 Dry plant equivalent : 6,400 mg Potency : 36 % Anthocyanins | 80 mg | Not calculated |
Non-medicinal ingredients
Bisglycinate de magnésium, NA, Eau purifiée, Bioflavonoïdes d'agrumes, Stéarate de magnésium, Dioxyde de silicium, Mélatonine, Acide ascorbique, Cellulose microcristalline, Riboflavine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of/Provides antioxidants. Used in Herbal Medicine to help relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs. Used in Herbal Medicine to help slow the progression of disorders of the eye, such as diabetic and hypertensive retinopathy, and macular degeneration.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80129388
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.